Wells Fargo & Company Prime Medicine, Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 96,181 shares of PRME stock, worth $273,154. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,181
Previous 171,468
43.91%
Holding current value
$273,154
Previous $663,000
57.77%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRME
# of Institutions
135Shares Held
63MCall Options Held
50.1KPut Options Held
30.9K-
Alphabet Inc. Mountain View, CA15.1MShares$42.8 Million3.11% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.15MShares$14.6 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$14.5 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.98MShares$11.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$10.4 Million0.0% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $272M